✦ LIBER ✦

Phase III trial of paclitaxel (P), carboplatin (C), and irinotecan (CPT-11), in advanced or metastatic non-small-cell lung cancer (NSCLC)

✍ Scribed by Socinski, MA; Sandler, AB; Petit, RG; Steagall, A; Hanover, CK; Natale, RB; Miller, LL

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multi-center study with paclitaxel (P)/c

✍ Glorieux, P; Ortmanns, P; Marien, S; Degives, R; Degraeve, D; Potvin, M; Grauwel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 206 KB

O-082 A randomized phase III trial compa

✍ Blumenschein, G.; Ludwig, C.; Thomas, G.; Tan, E.; Fanucchi, M.; Santoro, A.; Cr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

144 Phase III study of docetaxel and iri

✍ Kudoh, S.; Negoro, S.; Masuda, N.; Sugiura, T.; Shimokata, H.; Fukuoka, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Phase I study of irinotecan (CPT-11) and

✍ Kakolyris, S; Kouroussis, C; Souglakos, J; Androulakis, N; Mavroudis, D; Kalbaki 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 96 KB

11 Treatment of advanced non-small cell

✍ Agarwal, Sandeep 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Paclitaxel (T) and carboplatin (C): A ph

✍ Fírvida, J.L; Amenedo, M; Salgado, M; Gonzalez-Quintas, A; Garcia Mata, J; Losad 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB